BioMotiv aims to advance a portfolio of discoveries into new medicines through an innovative, mission-driven model that efficiently aligns capital and collaborations for the benefit of inventors and investors, and ultimately physicians and patients.

The NYU Innovation Venture Fund is a seed-stage venture capital fund created in 2010 to invest in startups founded by and/or commercializing technologies and intellectual property developed by NYU students, faculty and researchers.